Neil W. Gibson

7.5k citations

86 papers · 5.2k indexed · 2 hit papers · h-index 34

Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents 15
Oncology top 1%
Cancer Research top 2%
Molecular Biology top 2%
- Cancer therapeutics and mechanisms 23
- PI3K/AKT/mTOR signaling in cancer 9
- DNA and Nucleic Acid Chemistry 7
- DNA Repair Mechanisms 6
Genetics top 5%
Organic Chemistry
- Synthesis and Biological Evaluation 11
- Synthesis and Characterization of Heterocyclic Compounds 6
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 7

Co-authors: David Ross John D. Haley Elizabeth Buck David Siegel Kenneth K. Iwata Stuart Thomson Filippo Petti Graeme Griffin
Cited by: Toxicology Oncology Cancer Research
Journals: Journal of Biological Chemistry (1 paper)PLoS ONE (1 paper)Biochemistry (9 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Neil W. Gibson

86 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Neil W. Gibson

Since Specialization

Citations

This map shows the geographic impact of Neil W. Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil W. Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil W. Gibson more than expected).

Fields of papers citing papers by Neil W. Gibson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil W. Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil W. Gibson. The network helps show where Neil W. Gibson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Neil W. Gibson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neil W. Gibson Line = papers co-authored together Neil W. Gibson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches PLoS ONE ·Wenxue Ma,Alejandro Gutiérrez,Daniel Goff,Ifat Geron,Anil Sadarangani,Christina Jamieson,Angela C. Court,Alice Shih,Qingfei Jiang,Christina Wu,Kang Li,Kristen M. Smith,Leslie Crews,Neil W. Gibson,Ida Deichaite,Sheldon Morris,Ping Wei,Dennis A. Carson,A. Thomas Look,(unknown),(unknown)	2012	29
2	Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin Molecular Cancer Therapeutics ·Shripad V. Bhagwat,Prafulla C. Gokhale,Andrew P. Crew,Andy Cooke,Yan Yao,Christine Mantis,Jennifer Kahler,Jennifer E. Workman,Mark Bittner,Lorina Dudkin,David Epstein,Neil W. Gibson,Robert Wild,Lee D. Arnold,Peter J. Houghton,Jonathan A. Pachter	2011	159
3	Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors Cancer Research ·Elizabeth Buck,Alexandra Eyzaguirre,Maryland Rosenfeld-Franklin,Stuart Thomson,Mark J. Mulvihill,Sharon Barr,Eric Brown,Mathew O'Connor,Yan Yao,Jonathan A. Pachter,Mark Miglarese,David Epstein,Kenneth K. Iwata,John D. Haley,Neil W. Gibson,Qunsheng Ji	2008	164
4	Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions Clinical & Experimental Metastasis ·Sharon Barr,Stuart Thomson,Elizabeth Buck,Suzanne Russo,Filippo Petti,Izabela Sujka-Kwok,Alexandra Eyzaguirre,Maryland Rosenfeld-Franklin,Neil W. Gibson,Mark Miglarese,David Epstein,Kenneth K. Iwata,John D. Haley	2008	169
5	A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor–dependent tumor growth in vivo Molecular Cancer Therapeutics ·Qunsheng Ji,Mark J. Mulvihill,Maryland Rosenfeld-Franklin,Andrew Cooke,Lixin Feng,Gilda Mak,Matthew O’Connor,Yan Yao,Caroline Pirritt,Elizabeth Buck,Alexandra Eyzaguirre,Lee D. Arnold,Neil W. Gibson,Jonathan A. Pachter	2007	118
6	Inhibition of IGF-1R by OSI-906 potentiates efficacy of various molecular targeted agents by blocking feedback loops converging at the level of IRS-1 Molecular Cancer Therapeutics ·Elizabeth Buck,Alexandra Eyzaguirre,Maryland Rosenfeld-Franklin,Sharon Barr,Jonathan A. Pachter,Kenneth K. Iwata,John D. Haley,Neil W. Gibson,Qunsheng Ji	2007	1
7	Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials Molecular Cancer Therapeutics ·Qunsheng Ji,Mark J. Mulvihill,Maryland Rosenfeld-Franklin,Elizabeth Buck,Andrew Cooke,Alexandra Eyzaguirre,Gilda Mak,Matthew O’Connor,Caroline Pirritt,Yan Yao,Neil W. Gibson,Jonathan A. Pachter	2007	4
8	Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells Molecular & Cellular Proteomics ·April Thelemann,Filippo Petti,Graeme Griffin,Ken Iwata,Tony Hunt,Tina Settinari,David Fenyö,Neil W. Gibson,John D. Haley	2005	119
9	Role of NAD(P)H:Quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin Biochemical Pharmacology ·Howard D. Beall,Yafei Liu,David Siegel,Emiko M. Bolton,Neil W. Gibson,David Ross	1996	62
10	Reactive Oxygen Species and DNA Damage in 2-Bromo-(glutathione-S-yl) hydroquinone-Mediated Cytotoxicity Archives of Biochemistry and Biophysics ·J.J.W.M. Mertens,Neil W. Gibson,S S Lau,Terrence J. Monks	1995	40
11	Molecular dynamics simulations provide A structural basis for the experimentally observed nucleotide preferences for DNA interstrand cross-links induced by aziridinylbenzoquinones Biochemistry ·Ian S. Haworth,Chong Soon Lee,Masayuki Yuki,Neil W. Gibson	1993	5
12	DNA interstrand cross-links induced by the cyclopropylpyrroloindole antitumor agent bizelesin are reversible upon exposure to alkali Biochemistry ·Chong-Soon Lee,Neil W. Gibson	1993	22
13	Nucleotide preferences for DNA interstrand cross-linking induced by the cyclopropylpyrroloindole analog U-77,779 Biochemistry ·Chong Soon Lee,Neil W. Gibson	1993	21
14	DT-diaphorase in activation and detoxification of quinones Cancer and Metastasis Reviews ·David Ross,David Siegel,Howard D. Beall,A. S. Prakash,Ríona Mulcahy,Neil W. Gibson	1993	166
15	Bioreductive activation of mitomycin C by DT-diaphorase Biochemistry ·David Siegel,Howard D. Beall,Claudia Senekowitsch,Masaji Kasai,Hitoshi Arai,Neil W. Gibson,David Ross	1992	137
16	Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymic reduction by DT-diaphorase Biochemistry ·Chong Soon Lee,J.A. Hartley,Mark Berardini,John Butler,David Siegel,David Ross,Neil W. Gibson	1992	45
17	Effect of methylated forms of selenium on cell viability and the induction of DNA strand breakage Biochemical Pharmacology ·Adrian C. Wilson,Henry J. Thompson,Pepper Schedin,Neil W. Gibson,Howard E. Ganther	1992	64
18	A note on the inhibition of DT-diaphorase by dicoumarol Free Radical Biology and Medicine ·Peter C. Preusch,David Siegel,Neil W. Gibson,David Ross	1991	67
19	DNA crosslinking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction Biochemistry ·J.A. Hartley,Mark Berardini,Mauro Ponti,Neil W. Gibson,Andrew S. Thompson,David E. Thurston,Brigid M. Hoey,John Butler	1991	33
20	A comparative study of the anti-tumour activity of N-methylformamide and related compounds. British Journal of Cancer ·Simon Langdon,Neil W. Gibson,John A. Hickman,Andreas J. Gescher,Malcolm F. G. Stevens	1981	1

About Neil W. Gibson

Neil W. Gibson is a scholar working on Toxicology, Organic Chemistry and Cancer Research, having authored 86 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (23 papers), Bioactive Compounds and Antitumor Agents (15 papers), Synthesis and Biological Evaluation (11 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), DNA and Nucleic Acid Chemistry (7 papers), Lung Cancer Treatments and Mutations (7 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Toxicology (773 citations), Oncology (1.7k citations) and Cancer Research (832 citations). Neil W. Gibson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include David Ross, John D. Haley, Elizabeth Buck, David Siegel, Kenneth K. Iwata, Stuart Thomson, Filippo Petti, Graeme Griffin, Eric Brown and Alexandra Eyzaguirre. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact